Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hash Will Be HHS Health Reform Office Director As Administration Regroups For New Congress

This article was originally published in The Pink Sheet Daily

Executive Summary

White House health reform operative Michael Hash will move to director of the HHS Office of Health Reform, succeeding Jeanne Lambrew.

You may also be interested in...

People In The News: Changes At Impax, Isarna, Sorrento, Macrogenics

Actavis global R&D exec G. Frederick Wilkinson joins Impax as president and CEO; FDA veteran Shaw Chen moves to Polaris. On the government side, Senate HELP Cmte. Is slated to review Sylvia Burwell’s nomination for HHS secretary and Michael Hash is retiring from the department. More personnel announcements in this month’s column.

Getting To Know HHS: Insurance Oversight Management Team Is Complete

Top level staffing for the HHS Office of Consumer Information and Insurance Oversight will be complete when former Pennsylvania Insurance Commissioner Joel Ario joins Aug. 30

HHS Health Reform Team Put In Place – And For Some, That Place Is The White House

Senior Advisor Hash will help develop "specific aspects" of legislation, on assignment to the White House.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts